146 related articles for article (PubMed ID: 145516)
1. Defective transport of thymidine by cultured cells resistant to 5-bromodeoxyuridine.
Lynch TP; Cass CE; Paterson AR
J Supramol Struct; 1977; 6(3):363-74. PubMed ID: 145516
[TBL] [Abstract][Full Text] [Related]
2. Fluctuations in nucleoside uptake and binding of the inhibitor of nucleoside transport, nitrobenzylthioinosine, during the replication cycle of HeLa cells.
Cass CE; Dahlig E; Lau EY; Lynch TP; Paterson AR
Cancer Res; 1979 Apr; 39(4):1245-52. PubMed ID: 421208
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of nucleoside transport in mammalian cells. Two types of transport activity in L1210 and other cultured neoplastic cells.
Belt JA
Mol Pharmacol; 1983 Nov; 24(3):479-84. PubMed ID: 6314117
[TBL] [Abstract][Full Text] [Related]
4. Defective facilitated diffusion of nucleosides, a primary mechanism of resistance to 5-fluoro-2'-deoxyuridine in the HCT-8 human carcinoma line.
Sobrero AF; Moir RD; Bertino JR; Handschumacher RE
Cancer Res; 1985 Jul; 45(7):3155-60. PubMed ID: 3159474
[TBL] [Abstract][Full Text] [Related]
5. Resistance of colorectal cancer cells to 5-FUdR and 5-FU caused by Mycoplasma infection.
Jetté L; Bissoon-Haqqani S; Le François B; Maroun JA; Birnboim HC
Anticancer Res; 2008; 28(4B):2175-80. PubMed ID: 18751392
[TBL] [Abstract][Full Text] [Related]
6. Interaction of 2'-halogeno-2'-deoxyuridines with the human erythrocyte nucleoside transport mechanism.
Gati WP; Knaus EE; Wiebe LI
Mol Pharmacol; 1983 Jan; 23(1):146-52. PubMed ID: 6223203
[TBL] [Abstract][Full Text] [Related]
7. CSF-1 stimulates nucleoside transport in S1 macrophages.
Meckling-Gill KA; Guilbert L; Cass CE
J Cell Physiol; 1993 Jun; 155(3):530-8. PubMed ID: 8491790
[TBL] [Abstract][Full Text] [Related]
8. Amphibian cells in culture. II. Isolation of drug-resistant variants and an asparagine-independent variant.
Chinchar GD; Sinclair JH
J Cell Physiol; 1978 Sep; 96(3):343-54. PubMed ID: 307557
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of membrane transport of 5-fluoro[6-3H]deoxyuridine into L5178Y mouse leukemia cells.
Wigler PW; Schluter DN
Cancer Res; 1976 Sep; 36(9 pt.1):3207-11. PubMed ID: 135641
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic transformation of C3H/10T1/2 clone 8 mouse embryo cells by halogenated pyrimidine nucleosides.
Jones PA; Benedict WF; Baker MS; Mondal S; Rapp U; Heidelberger C
Cancer Res; 1976 Jan; 36(1):101-7. PubMed ID: 129280
[TBL] [Abstract][Full Text] [Related]
11. Binding of the nucleoside transport inhibitor nitrobenzylthioinosine to HeLa cells.
Lauzon GJ; Paterson AR
Mol Pharmacol; 1977 Sep; 13(5):883-91. PubMed ID: 895723
[No Abstract] [Full Text] [Related]
12. Transport and countertransport of thymidine in ATP depleted and thymidine kinase-deficient Novikoff rat hepatoma and mouse L cells: evidence of a high Km facilitated diffusion system with wide nucleoside specificity.
Plagemann PG; Marz R; Erbe J
J Cell Physiol; 1976 Sep; 89(1):1-18. PubMed ID: 956273
[TBL] [Abstract][Full Text] [Related]
13. Initial rate kinetics of the transport of adenosine and 4-amino-7-(beta-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidine (tubercidin) in cultured cells.
Harley ER; Paterson AR; Cass CE
Cancer Res; 1982 Apr; 42(4):1289-95. PubMed ID: 7060008
[TBL] [Abstract][Full Text] [Related]
14. Collateral resistance of a dideoxycytidine-resistant cell line to 5-fluoro-2'-deoxyuridine.
Agarwal RP; Han T; Fernandez M
Biochem Biophys Res Commun; 1999 Sep; 262(3):657-60. PubMed ID: 10471381
[TBL] [Abstract][Full Text] [Related]
15. Absence of binding sites for the transport inhibitor nitrobenzylthioinosine on nucleoside transport-deficient mouse lymphoma cells.
Cass CE; Kolassa N; Uehara Y; Dahlig-Harley E; Harley ER; Paterson AR
Biochim Biophys Acta; 1981 Dec; 649(3):769-77. PubMed ID: 7317429
[TBL] [Abstract][Full Text] [Related]
16. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies.
Jackman AL; Alison DL; Calvert AH; Harrap KR
Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731
[TBL] [Abstract][Full Text] [Related]
17. Isolation of drug resistant mutants of varicella-zoster virus: cross resistance of acyclovir resistant mutants with phosphonoacetic acid and bromodeoxyuridine.
Shiraki K; Ogino T; Yamanishi K; Takahashi M
Biken J; 1983 Mar; 26(1):17-23. PubMed ID: 6312958
[TBL] [Abstract][Full Text] [Related]
18. Comparative studies of fluorinated pyrimidines with various cell lines.
Umeda M; Heidelberger C
Cancer Res; 1968 Dec; 28(12):2529-38. PubMed ID: 4302536
[No Abstract] [Full Text] [Related]
19. Development and characteristics of a subline of Ehrlich ascites carcinoma cells persistently resistant to 5-fluoro-2'-deoxyuridine.
Jastreboff MM; Zielińska ZM
Acta Biochim Pol; 1983; 30(2):185-91. PubMed ID: 6223475
[TBL] [Abstract][Full Text] [Related]
20. The Na+,K+,2Cl- -cotransport system in HeLa cells and HeLa cell mutants exhibiting an altered efflux pathway.
Kort JJ; Koch G
J Cell Physiol; 1989 Oct; 141(1):181-90. PubMed ID: 2777900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
